CD86 and neoplasm: Manual gating (Supplemental Figure 7D) confirmed these findings and showed that CD86 blockade in the context of RT increased the frequency of CD44+TCF-1– cells among CD8+ T cells in both the TdLN and tumor (Figure 6G).